Related Experiment Video
Updated: Aug 6, 2026

Profiling Thiol Redox Proteome Using Isotope Tagging Mass Spectrometry
Published on: March 24, 2012
Metabolomic and genomic insights into TMA degradation by a novel halotolerant strain - Paracoccus sp. PS1
Madhupa Seth1, Priyajit Mondal1, Dhritishree Ghosh1
1Department of Microbiology, The University of Burdwan, Burdwan, Purba Bardhaman, 713104, West Bengal, India.
Abstract:
Trimethylamine N-oxide (TMAO) is a gut metabolite that acts as a biomarker for chronic diseases, and is generated by the oxidation of trimethylamine (TMA) produced by gut microflora. Since, microbial degradation of TMA is predicted to be used to restrict the production of TMAO, we aimed to isolate bacterial strains that could effectively degrade TMA before being oxidized to TMAO. As marine fish is considered to have a rich content of TMAO, we have isolated TMA degrading isolates from fish skin. Out of the fourteen isolates, depending on their rapid TMA utilization capability in mineral salt medium supplemented with TMA as a sole carbon and nitrogen source, isolate PS1 was selected as our desired isolate. Its TMA degrading capacity was further confirmed through spectrophotometric, Electrospray Ionization Time-of-Flight Mass Spectrometry (ESI TOF-MS) and High performance liquid chromatography (HPLC) analysis and in silico analysis of whole genome (WG) gave further insights of protein into its TMA degradation pathways. PS1 was taxonomically identified as Paracoccus sp. based on its 16S rRNA and whole genome sequence analysis. As PS1 possesses the enzymes required for degradation of TMA, clinical use of this isolate has the potential to reduce TMAO generation in the human gut.
Insights
Researchers isolated a novel bacterial strain, Paracoccus sp. PS1, capable of degrading trimethylamine (TMA). This discovery offers a potential probiotic strategy to reduce trimethylamine N-oxide (TMAO) levels in the human gut, mitigating chronic disease risks.
Area of Science:
- Microbiology
- Gut Microbiome Research
- Metabolic Engineering
Background:
- Trimethylamine N-oxide (TMAO) is a metabolite linked to chronic diseases.
- TMAO is produced by the oxidation of trimethylamine (TMA), generated by gut bacteria.
- Reducing TMA production is a strategy to limit TMAO formation.
Purpose of the Study:
- To isolate and characterize bacterial strains capable of degrading TMA.
- To identify a potential probiotic for reducing TMAO generation in the gut.
Main Methods:
- Isolation of TMA-degrading bacteria from marine fish skin.
- Screening isolates based on TMA utilization.
- Confirmation of TMA degradation using spectrophotometry, ESI TOF-MS, and HPLC.
- Whole genome sequencing and 16S rRNA analysis for taxonomic identification and pathway elucidation.
Main Results:
- Fourteen TMA-degrading isolates were obtained from fish skin.
- Isolate PS1 demonstrated rapid TMA utilization and degradation.
- Genomic analysis identified PS1 as Paracoccus sp. and revealed TMA degradation pathways.
- The isolate possesses enzymes crucial for TMA breakdown.
Conclusions:
- Paracoccus sp. PS1 is an effective TMA degrader.
- This isolate holds potential for clinical applications to reduce gut TMAO production.
- Further research may lead to novel probiotic interventions for TMAO-related diseases.
Related Concept Videos
Hyperthermophilic Bacteria
Bacterial Phylum Tenericutes
Deep Sea Microbial Ecology
Microbial Bioremediation of Plastics

